Groupama Asset Managment »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.7M 2.0M 1.33
2024-06-30 $1.3M 1.2M 1.12
2024-03-31 $1.1M 1.2M 0.90
2023-12-31 $561k 600k 0.94

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Amazon (AMZN)
Agnico (AEM)
Motorola Solutions Com New (MSI)
Thermo Fisher Scientific (TMO)
Parker-Hannifin Corporation (PH)
Wal-Mart Stores (WMT)
Meta Platforms Cl A (META)
Boston Scientific Corporation (BSX)

View all positions for Groupama Asset Managment

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
Point72 Asset Management
LMR Partners
Balyasny Asset Management
Alberta Investment Management Corporation
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
Lombard Odier Asset Management
Absolute Investment Advisers
Citadel Advisors
Linden Advisors
Calamos Advisors
Tenor Capital Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1